This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level and pathway-level research relating to healthy blood sugar / glucose support, carbohydrate metabolism and metabolic pathway research. It does not represent additional ARTG indications for NT2.
NT2 is relevant to practitioners interested in healthy glucose metabolism, carbohydrate metabolism, botanical metabolic pathway research, chromium nutrition, bitter melon research, green tea extract research and ginseng-related metabolic research.
Momordica charantia, also known as bitter melon, has been studied in relation to glucose metabolism, lipid metabolism, gut health modulation and metabolic pathway research. A systematic review and meta-analysis of randomised controlled trials examined Momordica charantia supplementation in glycaemic control and lipid profile research settings. This information supports practitioner education around ingredient-level metabolic research, but should not be interpreted as a claim that NT2 treats diabetes, hyperglycaemia, hyperinsulinaemia or metabolic disease.
Coptis chinensis is included as part of the formula’s botanical metabolic profile. Coptis-derived berberine-type constituents have been discussed in professional literature in relation to glucose metabolism, lipid metabolism, gut microbiota and intestinal environment research. This information is provided as ingredient-level education only and does not represent a disease-treatment indication for NT2.
Chromium is a trace mineral relevant to carbohydrate metabolism and glucose pathway research. Scientific reviews have discussed chromium supplementation in relation to glycaemia and serum lipids, while also noting uncertainty and mixed evidence. This supports cautious practitioner education rather than strong disease-treatment claims.
Panax ginseng has been studied in relation to glucose metabolism and fasting blood glucose outcomes in systematic review literature. This supports practitioner education around Panax ginseng’s broader metabolic research profile, while the product claim should remain limited to healthy blood sugar and carbohydrate metabolism support.
Camellia sinensis, Astragalus membranaceus, Lonicera japonica and Nelumbo nucifera are included as part of the broader botanical formula profile. Practitioner interest may include antioxidant pathways, metabolic pathway research, carbohydrate metabolism, phytochemical constituents and general wellbeing contexts.
The combination of Momordica, chromium, Coptis, Panax ginseng and related botanicals supports practitioner education around healthy blood sugar support and glucose / sugar / carbohydrate metabolism. This information is provided for practitioner education only and does not represent additional ARTG indications for NT2.
References available to registered practitioners on request.
